| scholarly article | Q13442814 |
| P2093 | author name string | M Bard | |
| M A Kennedy | |||
| N D Lees | |||
| C Koegel | |||
| R Barbuch | |||
| K L Jensen-Pergakes | |||
| P2860 | cites work | Polyene resistance and the isolation of sterol mutants in Saccharomyces cerevisiae. | Q54656651 |
| Amphotericin B-resistant yeast infection in severely immunocompromised patients | Q68136440 | ||
| Stereochemical specificity for sterols in Saccharomyces cerevisiae | Q70246345 | ||
| Effect of side-chain structure on inhibition of yeast fatty-acid synthase by cerulenin analogues | Q70541899 | ||
| Brefeldin A causes a defect in secretion in Saccharomyces cerevisiae | Q70550595 | ||
| Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro | Q24671525 | ||
| The yeast gene ERG6 is required for normal membrane function but is not essential for biosynthesis of the cell-cycle-sparking sterol | Q27936224 | ||
| Construction and growth properties of a yeast strain defective in sterol 14-reductase | Q27938171 | ||
| 5-Fluoroorotic acid as a selective agent in yeast molecular genetics | Q28131614 | ||
| ESR determinations of membrane permeability in a yeast sterol mutant | Q28322566 | ||
| Stereoselective interaction of the azole antifungal agent SCH39304 with the cytochrome P-450 monooxygenase system isolated from Cryptococcus neoformans | Q28379017 | ||
| Gene isolation by complementation in Candida albicans and applications to physical and genetic mapping | Q33207252 | ||
| The gene encoding squalene epoxidase from Saccharomyces cerevisiae: cloning and characterization | Q33282125 | ||
| Isogenic strain construction and gene mapping in Candida albicans. | Q33961115 | ||
| Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters | Q35120105 | ||
| Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance. | Q35122459 | ||
| Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors | Q35127954 | ||
| Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum. | Q35132552 | ||
| Fluconazole tolerance in clinical isolates of Cryptococcus neoformans. | Q35134684 | ||
| Itraconazole resistance in Aspergillus fumigatus | Q35136791 | ||
| Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus | Q35137093 | ||
| Amphotericin B: current understanding of mechanisms of action | Q35247730 | ||
| Isolation of a cytochrome P-450 structural gene from Saccharomyces cerevisiae | Q36463806 | ||
| Mutations in LIS1 (ERG6) gene confer increased sodium and lithium uptake in Saccharomyces cerevisiae | Q36734931 | ||
| DEVELOPMENT OF RESISTANCE TO POLYENE ANTIBIOTICS IN CANDIDA ALBICANS. | Q37420103 | ||
| Targeted selection of recombinant clones through gene dosage effects | Q37510502 | ||
| Anti-Candida drugs--the biochemical basis for their activity | Q39685115 | ||
| Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata | Q39780155 | ||
| The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans | Q39784510 | ||
| Differences in crystal violet uptake and cation-induced death among yeast sterol mutants | Q39991038 | ||
| ESR determination of membrane order parameter in yeast sterol mutants | Q40236298 | ||
| Human mycoses: drugs and targets for emerging pathogens | Q40737322 | ||
| Ergosterol biosynthesis inhibition: a target for antifungal agents | Q41147969 | ||
| Identification of cDNAs encoding sterol methyl-transferases involved in the second methylation step of plant sterol biosynthesis | Q48049104 | ||
| Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin. | Q50769952 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida albicans | Q310443 |
| P304 | page(s) | 1160-1167 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants | |
| P478 | volume | 42 |
| Q27932829 | A functional variomics tool for discovering drug-resistance genes and drug targets |
| Q41774705 | A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata |
| Q30656690 | An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans |
| Q28818603 | Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis |
| Q39751373 | Antifungal resistance and new strategies to control fungal infections |
| Q34085830 | Calcineurin is essential for survival during membrane stress in Candida albicans |
| Q58105713 | Candida albicans gains azole resistance by altering sphingolipid composition |
| Q35165864 | Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents |
| Q30827584 | Candida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target site |
| Q42477429 | Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes |
| Q28548587 | Changes in the Sterol Composition of the Plasma Membrane Affect Membrane Potential, Salt Tolerance and the Activity of Multidrug Resistance Pumps in Saccharomyces cerevisiae |
| Q30863545 | Cloning and sequencing of the Candida albicans C-4 sterol methyl oxidase gene (ERG25) and expression of an ERG25 conditional lethal mutation in Saccharomyces cerevisiae |
| Q33805404 | Comparative genomics allowed the identification of drug targets against human fungal pathogens |
| Q38867619 | Control of Candida albicans morphology and pathogenicity by post-transcriptional mechanisms. |
| Q41816687 | Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae |
| Q45215460 | Disruption of ergosterol biosynthesis, growth, and the morphological transition in Candida albicans by sterol methyltransferase inhibitors containing sulfur at C-25 in the sterol side chain. |
| Q39955972 | Disruption of the Candida albicans CYB5 gene results in increased azole sensitivity |
| Q34622554 | Drug strategies targeting CYP51 in neglected tropical diseases |
| Q39671060 | Drug susceptibilities of yeast cells are affected by membrane lipid composition |
| Q34973741 | Dual effects of plant steroidal alkaloids on Saccharomyces cerevisiae |
| Q36106885 | ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis |
| Q93221228 | ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait |
| Q44030158 | ERG6 and PDR5 regulate small lipophilic drug accumulation in yeast cells via distinct mechanisms |
| Q55259114 | Effect of Cinnamaldehyde and Citral Combination on Transcriptional Profile, Growth, Oxidative Damage and Patulin Biosynthesis of Penicillium expansum. |
| Q26750816 | Emerging Threats in Antifungal-Resistant Fungal Pathogens |
| Q90574541 | Erg6 affects membrane composition and virulence of the human fungal pathogen Cryptococcus neoformans |
| Q34735206 | Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei |
| Q46257698 | Fluconazole Resistant Candida auris is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses |
| Q40148508 | Identification and Mode of Action of a Plant Natural Product Targeting Human Fungal Pathogens. |
| Q73864701 | Influence of methylfenpropidine on growth, sterol content and fatty acid composition of Candida albicans |
| Q37002720 | Mechanism-based enzyme inactivators of phytosterol biosynthesis |
| Q58514822 | Modification of membrane lipid compositions in single-celled organisms – From basics to applications |
| Q36563876 | Multiple resistance mechanisms to azole antifungals in yeast clinical isolates. |
| Q36198245 | Parallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast |
| Q27932598 | Positive and negative regulation of squalene synthase (ERG9), an ergosterol biosynthetic gene, in Saccharomyces cerevisiae |
| Q36141819 | Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant |
| Q36191450 | Rapid Evaporative Ionisation Mass Spectrometry (REIMS) Provides Accurate Direct from Culture Species Identification within the Genus Candida |
| Q42948674 | Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth |
| Q34772205 | Resistance of human fungal pathogens to antifungal drugs |
| Q28344339 | Sterol methyltransferase 1 controls the level of cholesterol in plants |
| Q44658840 | Sterol methyltransferase2: purification, properties, and inhibition |
| Q37189877 | The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn |
| Q33261315 | Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum |
| Q36101724 | Transcriptional profiling analysis of Penicillium digitatum, the causal agent of citrus green mold, unravels an inhibited ergosterol biosynthesis pathway in response to citral |
| Q77343314 | Transcriptional regulation of the squalene synthase gene (ERG9) in the yeast Saccharomyces cerevisiae |
| Q28818537 | Widespread Genetic Incompatibilities between First-Step Mutations during Parallel Adaptation of Saccharomyces cerevisiae to a Common Environment |
| Q50879488 | α-Bisabolol inhibits Aspergillus fumigatus Af239 growth via affecting microsomal ∆24-sterol methyltransferase as a crucial enzyme in ergosterol biosynthesis pathway. |
Search more.